AWA
GILD icon

Acorn Wealth Advisors’s Gilead Sciences GILD Stock Holding History

Acorn Wealth Advisors’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$332K Buy
2,630
+333
+14% +$43.9K 0.08% 209
2026
Q1 		$320K Buy
2,297
+15
+0.7% +$2.1K 0.09% 187
2025
Q4 		$280K Sell
2,282
-101
-4% -$12.3K 0.08% 216
2025
Q3 		$265K Buy
2,383
+13
+0.5% +$1.48K 0.08% 231
2025
Q2 		$263K Buy
2,370
+7
+0.3% +$745 0.1% 204
2025
Q1 		$265K Buy
2,363
+14
+0.6% +$1.45K 0.11% 190
2024
Q4 		$217K Buy
+2,349
New +$211K 0.09% 221
2022
Q1 		– Sell
-2,814
Closed -$204K – 178
2021
Q4 		$204K Buy
+2,814
New +$194K 0.13% 174
2018
Q4 		– Sell
-4,678
Closed -$328K – 118
2018
Q3 		$328K Sell
4,678
-1
-0% -$76 0.32% 67
2018
Q2 		$334K Buy
4,679
+72
+2% +$5.08K 0.28% 63
2018
Q1 		$340K Sell
4,607
-50
-1% -$3.98K 0.29% 59
2017
Q4 		$345K Buy
+4,657
New +$354K 0.31% 56

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Acorn Wealth Advisors's GILD Position: Q2 2026 in Review

Acorn Wealth Advisors increased its Gilead Sciences (GILD) stake by 14% in Q2 2026, buying an estimated $43.9K and bringing the position to 2,630 shares worth $332K. The position accounts for 0.08% of the portfolio, ranked #209.

Acorn Wealth Advisors first reported a position in GILD in Q4 2017 and has held it in 12 quarters since. The position peaked at $345K in Q4 2017. 2,268 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Acorn Wealth Advisors held 2,630 shares of Gilead Sciences worth $332K as of Q2 2026.
  • Acorn Wealth Advisors bought 333 Gilead Sciences shares in Q2 2026, an estimated $43.9K.
  • Gilead Sciences made up 0.08% of Acorn Wealth Advisors's portfolio in Q2 2026, its #209 holding.
  • Acorn Wealth Advisors first reported a position in Gilead Sciences in Q4 2017 and has held it in 12 quarters since.
  • Acorn Wealth Advisors's Gilead Sciences position peaked at $345K in Q4 2017.
  • 2,268 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Acorn Wealth Advisors's 13F filing for Q2 2026, filed 30 Jul 2026.